The newsletter is not displayed correctly? Please click here.

Newsletter 5/2010

18 March 2010

[gs]  

A Splendid Review of 79 or 80 or 81 Life Sciences Events of the Last Twelve Months

or: Dr. Fischer of Geneva, revisited

If you do not wish to receive this newsletter anymore, just reply to this mail without any comment and you will be taken off the mailing list.

Dear reader,
 

this [gs] newsletter provides a kind of a "Year in Review".

A fine, splendid selection of 79 or 80 or 81 life science events from the last twelve months. Carefully chosen from the gene-sensor.com database to provide our honoured readership with a slight taste of amusement, excitement and surprise. From local grants to global collaborations; from multi-billion dollar acquisitions to small alliances. A hand-edited list by Mr. Jones himself.

We think there is something new and interesting in the following list for nearly everbody!

Please note: Entries marked with "Free [MSC]" can be accessed by anybody on the free mass spectrometry web portal www.Mass-Spec-Capital.com, while all other entries are for subscibers to the www.gene-sensor.com professional services only! 

----------------------------------------------------------------------------------- 

[gs] Proudly Presents

A Splendid Review of 79 or 80 or 81 Life Sciences Events of the Last Twelve Months

by Mr. Jones himself

Free [MSC] Millipore–Merck (D): investment, 201002– acquistition €5.3b = $7.2b in cash $107/share 2010-02-28

Free [MSC] Eksigent–Danaher: investment, 201002 acquisition of liquid chromatography business from Eksigent by AB SCIEX 2010-02-16

Biocartis–Philips: molecular diagnostics platform, 201002 acquisition €na automated DNA/RNA molecular diagnostic testing platform from Philips 2010-02-10

Free [MSC] Finnzymes–Thermo Fisher: investment, 201002– acquisition announced 2010-02-01

Ignite Institute–Life Technologies: SOLiD system, 201001 supply Ignite will acquire 100 SOLiD 4 Systems from ABI 2010-01-28

ESE GmbH–Qiagen: investment, 201001 acquisition up to $19m in cash 2010-01-12

Protagen–Schweins T: board, 201001– joins supervisory board of Protagen AG main org Qiagen GmbH 2010-01-12

China (govt)–Illumina: HiSeq 2000 , 201001 purchase 128 HiSeq 2000 sequencing systems by BGI 2010-01-12

Qiagen–WuXi PharmaTech: molecular diagnostics, 201001– collab biomarker development facility staffed by WuXi with Qiagen technology 2010-01-11

Anachem–Mettler-Toledo: investment, 200910–201001 acquisition £7.8m in cash + up to £0.8m milestones from Diploma plc 2010-01-07

Free [MSC] InProcess Instruments–Pickuth A: management, 201001– managing director 2010-01-01

MagForce–Heinrich P: management, 201001– CEO before MediGene 1995–200904 CEO + Managing Director 2010-01-01

Free [MSC] Genetix–Danaher: investment, 200912–201001 acquisition £50m=$82m net of cash acquired recommended cash tender offer 85p/share 2009-12-18

Free [MSC] Danaher–Zerhouni EA: board, 200912–2011 joins as Board Director before NIH director 2002–2008 2009-12-10

Biocom–Google: Google Analytics, 200912 service existent Biocom Projektmanagement GmbH uses Google Analytics for biotechnologie.de 2009-12-06

Wiley–Google: online marketing, 200912 service BasePeak uses DoubleClick for banner ad section 2009-12-06

EBF–Mietzsch A: management, 200911 Secretary General main org Biocom AG 2009-11-24

cracker–X PRIZE Foundation: grant, 200710– team cracker takes part in Archon X PRIZE for Genomics competition to map 10 human genomes in 10 days 2009-11-17

Free [MSC] BioTrove–Life Technologies: investment, 200911–200912 acquisition €na 2009-11-10

SABiosciences–Qiagen: investment, 200911–200912 acquisition $90m in cash subject to customary purchase price adjustements 2009-11-09

MIT–Illumina: Genome Analyzer, 200911 supply purchase addit 30 GAIIx systems by Broad Institute bringing total to 89 GA systems 2009-11-05

Institute for Systems Biology–Complete Genomics: DNA sequencing service, 200911– sequencing 100 human genomes within 6 months for ISB Huntington study 2009-11-02

AlgoNomics–Lonza: investment, 200911 acquisition €na 2009-11-02

Probiodrug–SEVERAL: investment, 200911 financing round Series B €36m incl new + lead investors BB Biotech + Edmond de Rothschild Investment Partners 2009-11-02

Univ Bremen–Stiftung Bremer Wertpapierbörse: grant, 200911– SBW is supporting chair for MR imaging at Dept of Physics + Fraunhofer MEVIS 2009-11-01

AnaSpec–Eurogentec: investment, 200910 acquisition 2009-10-23

HandyLab–Becton Dickinson: investment, 200910– acquisition €na announced 2009-10-23

Free [MSC] Roche–Kinaxo: biomarker identification, 200910– service €na support using PhosphoScout techn for Roche Diagnostics GmbH Penzberg 2009-10-21

Biocartis–SEVERAL: investment, 200910 financing round Series A €10m lead investor Aescap Venture 2009-10-15

Free [MSC] Thermo Fisher–Casper MN: management, 200910– named CEO before COO since 5/08 joined Thermo Fisher 12/01 before Kendro CEO before Dade Behring Americas 2009-10-15

Amsterdam Molecular–Aldag J: management, 200910– CEO before Evotec –200812 CEO before MAN GHH 2009-10-05

Free [MSC] Bayer–Dekkers ME: management, 200910– CEO before Thermo Fisher CEO since 2002 + before COO before AlliedSignal before GE 2009-10-01

JnJ–Crucell: MAbs + vaccines, 200909– collab strategic developm treatm + prevention of influenza et al Ortho-McNeil-Janssen Pharma 2009-09-28

Solvay–Abbott: investment, 200909– acquisition Solvay Pharmaceuticals €4.8b with €4.5b in cash + €300m milestones + assumption liabilities €400m 2009-09-28

DxS–Qiagen: investment, 200909 acquisition $95m in cash + $35m commercial milestones 2009-09-22

Qiagen–Roche: real-time PCR technology, 200909– addit license €na incl HRM technology ww for all applications from Roche + Idaho Technology 2009-09-17

Cadbury–Kraft Foods: investment, 200909– unfriendly takeover offer £10.2b with 300p/share in cash + 0.2589 new Kraft Foods shares/share 2009-09-07

Free [MSC] BRAHMS–Thermo Fisher: investment, 200909–200910 acquisition €330m incl debt + other liabilities 2009-09-03

Sepracor–Sumitomo: investment, 200909– acquisition $2.6b cash tender offer $23/share by Dainippon Sumitomo Pharma 2009-09-03

Free [MSC] Life Technologies–Danaher: mass spectrometer, 200909–201002 acquisition $450m in cash mass spectrometry business from ABI 2009-09-02

Free [MSC] MDS–Danaher: mass spectrometer, 200909– acquisition $650m in cash AB Sciex mass spectrometry business + former Molecular Devices Corp 2009-09-02

Free [MSC] Galapagos–Kinaxo: drug discovery services, 200909 sales + support existent of Kinaxo services in Japan via BioFocus DPI Japan 2009-09-01

Free [MSC] Thermo Fisher–Battelle: H2/He collision cell technology, 200909 license existent for use in XSERIES 2 quqadruole ICP-MS analyzer 2009-09-01

Univ Bremen–Germany (govt): grant, 200909–201208 grant €1.855m from BMBF for Kompetenzzentrum Klinische Studien Bremen 2009-09-01

Free [MSC] VWR International–PerkinElmer: laboratory consumables, 200908– distribution US+CA consumables + minor accessories for spectroscopy + chromatography 2009-08-28

General Electric–TomTec Imaging: CardioArena software, 200908– collab integration of CardioArena into Centricity Cardiology from GE Healthcare 2009-08-25

Complete Genomics–SEVERAL: investment, 200908 financing round private Series D $45m incl new investors Essex Woodlands + OrbiMed Advisors 2009-08-24

Pacific Biosciences–SEVERAL: investment, 200908 financing round $68m incl strategic new investors Monsanto + Wellcome Trust 2009-08-12

BioAnaLab–Millipore: investment, 200908 acquisition 2009-08-10

ChemNavigator.com–Sigma-Aldrich: investment, 200908 acquisition 2009-08-06

Micromet–SEVERAL: investment, 200907–200908 public offering $80.5m net $75m 24m + 2.1m shares common stock $5/share 2009-07-29

SPSS–IBM: investment, 200907–200910 acquisition merger $1.2b in cash $50/share 2009-07-28

Free [MSC] Varian–Agilent: investment, 200907– acquisition $1.5b in cash $52/share announced 2009-07-27

Medarex–BMS: investment, 200907–200909 acquisition merger $2.4b cash tender offer for shares not already owned $16/share 2009-07-22

GSK–Enigma Diagnostics: Enigma ML, 200907– collab developm point-of-care influenza diagnostics 2009-07-21

Chatterjee–Life Technologies: SQL*LIMS, 200906–200908 acquisition €na sale SQL*LIMS business from ABI to LabVantage Solutions Inc 2009-06-30

InforSense–IDBS: investment, 200906–200907 acquisition £5m in cash + £0.8m milestones 2009-06-26

Monogram–LabCorp: investment, 200906–200908 acquisition $106.7m cash tender offer $4.55/share 2009-06-23

Roche–IT-IS International: LightCycler 1536 Multiwell Plate, –200906 development by IT-IS for Roche LightCycler 1536 System 2009-06-04

Evotec–Wenninger W: board, 200906– Supervisory Board Member proposed before Bayer AG 2009-06-04

Henkel–Sloning: protein engineering, 200906– collab developm enzymes for laundry + home care using SlonoMax mutant libraries 2009-06-01

Clemens–Peqlab: investment, 200906 acquisition 2009-06-01

Gen-Probe–Hull CW: management, 200905– CEO before COO since 200702 before Applied Biosystems 2009-05-18

Nanogen–Elitech: investment, 200905– acquisition $25.7m asset purchase agreement under Chapter 11 2009-05-14

Free [MSC] SlidePath–Genetix: investment, 200905 acquisition of SlidePath Ltd 2009-05-11

Free [MSC] Analytica of Branford–PerkinElmer: investment, 200905 acquisition €na 2009-05-05

ZytoVision–Germany (govt): grant, 200905–201204 grant €247k to ZytoVision GmbH in Double-CISH-LCD-Array project from BMBF 2009-05-01

General Electric–Analytik Jena: investment, 200904–200905 acquisition €na in cash of Biometra GmbH From Whatman GmbH 2009-04-30

MediGene–Mathias F: management, 200904– promoted CEO before Head Marketing + BusDev before Amgen GmbH General Manager before Servier Deutschland 2009-04-29

Invitek–Stratec: financing, 200904 acquisition cash €2.1m + 70.000 treasury stocks + max €0.35m variable purchase price incorporated under Robion AG 2009-04-23

Illumina–Agilent: Agilent SureSelect Target Enrichment System, 200904– collab co-marketing of integrated solution w Illumina Genome Analyzer 2009-04-20

China (govt)–Illumina: Genome Analyzer, 200904 supply purchase addit 12 Genome Analyzers by BGI bringing total to 29 systems 2009-04-16

MIT–Illumina: Genome Analyzer, 200904 supply purchase addit 22 Genome Analyzers by Broad Institute bringing total to 47 systems 2009-04-16

General Electric–Microsoft: healthcare IT, 200904– collab independent software vendor alliance agreement 2009-04-09

Finnzymes–Idaho Technology: SYBR Green technology, 200904– license SYBR Green I techn + melting curve analysis for real-time PCR from Idaho + Roche 2009-04-03

Peppermint–Stöckemann K: management, 200904– Managing Partner of Peppermint Management GmbH before 3i Deutschland 2009-04-01

Thermo Fisher–Idaho Technology: SYBR Green reagent, 200901– license non-excl to use SYBR Green I in real-time PCR 2009-03-31

Free [MSC] Bio-Rad–Bruker: biomarker discovery technology, 200903– collab excl developm + marketing products combining SELDI techn w MALDI-TOF/TOF 2009-03-23

Evotec–Lanthaler W: management, 200903– appointment CEO 2009-03-06

Olympus–Beckman Coulter: investment, 200902–200908 acquisition Olympus diagnostics business $800m with $500m in cash + $300m in new shares 2009-02-27

----------------------------------------------------------------------------------- 

After going through this intriguing list you may ask yourself: 

"Why exactly 79 or 80 or 81 events?" 

Well, you might visit Dr. Fischer of Geneva, to get the answer, because something is happening and you don’t know what it is, do you, Mr. Jones?!?

Thanks for reading, back in 14 days!

Marcus Lippold 

©2010 by [iito] Business Intelligence


NOTES & DISCLAIMER

Some links are available to subscribers only. As this newsletter is a free service, available to anybody without a contractual agreement, the writer disclaims any liabilities and explicitly advises you, not to use this information for your own business decisions. 

I hope you enjoy reading these lines as much as I have enjoyed writing them!

Thank you.

Marcus Lippold
Dipl.-Oek. (Economist)

[iito] Business Intelligence
Parkallee 24
28209 Bremen
Germany

Phone +49(0)-421-62659 196
Fax +49(0)-700-4-367-367-6
E-mail mlippold@iito.de
Web www.iito.de

This communication is confidential. If you are not the intended recipient, you should not copy or disclose the message to anyone, but should kindly notify the sender and delete the message.

A project of [iito] Business Intelligence© 2002-2009. Made in Germany.